This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidermolysis bullosa

Authoring team

Epidermolysis bullosa

This is a rare group of mechano-bullous disorders in which a lack of cohesion between certain layers of the skin produces blistering in response to minor trauma (1).

A change in proteins which are responsible for maintaining skin integrity results in formation of bullae (2).

In mild varieties blistering may occur (mainly on hands and feet) only during the summer months in response to the friction of walking. In more severe varieties blistering may begin in utero and the child may be stillborn (2). The condition is inherited and genetic counselling is indicated.

Ccurrent therapy only focuses on the management of wounds and pain (3).

Birch bark extract is recommended, within its marketing authorisation, as an option for treating partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa in people aged 6 months and over (4).

Major types include:

  • junctional
  • simplex
  • dystrophic (2)

Click here for example images of this condition

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.